Johnson & Johnson (JNJ) Common Equity (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Common Equity data on file, last reported at $81.2 billion in Q1 2026.

• Quarterly Common Equity rose 3.94% year-over-year to $81.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.2 billion (up 3.94% YoY) and the FY2025 annual result came in at $81.5 billion, up 14.06% from the prior year.
• Common Equity was little changed at $81.2 billion in Q1 2026 per JNJ's latest filing, from $81.5 billion in the prior quarter.
• The five-year high for Common Equity was $81.5 billion in Q4 2025, with the low at $68.8 billion in Q4 2023.
• Average Common Equity over 5 years is $74.8 billion, with a median of $74.7 billion recorded in 2022.
• Year-over-year, Common Equity gained 16.98% in 2022 and fell 10.46% in 2023.
• Johnson & Johnson's Common Equity stood at $74.6 billion in 2022, then slipped by 7.81% to $68.8 billion in 2023, then increased by 3.95% to $71.5 billion in 2024, then increased by 14.06% to $81.5 billion in 2025, then dropped by 0.44% to $81.2 billion in 2026.
• Business Quant data shows JNJ's Common Equity at $81.2 billion in Q1 2026, $81.5 billion in Q4 2025, and $79.3 billion in Q3 2025.